BioCentury | Jun 30, 2014
Financial News

Emcure withdraws IPO

...Ltd. , Pune, India Business: Pharmaceuticals, Generics Type: IPO Underwriters: BofA Merrill Lynch; Morgan Stanley; IDFC Capital...
BioCentury | Jun 20, 2014
Financial News

Emcure pulls IPO

...2013, the company filed to raise up to Rs3 billion ($49.8 million) in the offering. IDFC Capital...
BioCentury | Oct 28, 2013
Finance

Hoping to give thanks

...Ltd. (NSE; BSE) 6/26/13 Up to Rs3B ($50.6M) Mkt (drug) BofA Merrill Lynch; Morgan Stanley; IDFC Capital...
BioCentury | Jul 15, 2013
Financial News

Emcure proposes IPO

...to Rs3 billion ($50.6 million) Shares: TBD Price: TBD Underwriters: BofA Merrill Lynch; Morgan Stanley; IDFC Capital...
BioCentury | Jul 3, 2013
Financial News

Emcure, Intas file for Indian IPOs

...plan to sell 2.5 million Emcure shares in conjunction with the offering. BofA Merrill Lynch; IDFC Capital...
Items per page:
1 - 5 of 5
BioCentury | Jun 30, 2014
Financial News

Emcure withdraws IPO

...Ltd. , Pune, India Business: Pharmaceuticals, Generics Type: IPO Underwriters: BofA Merrill Lynch; Morgan Stanley; IDFC Capital...
BioCentury | Jun 20, 2014
Financial News

Emcure pulls IPO

...2013, the company filed to raise up to Rs3 billion ($49.8 million) in the offering. IDFC Capital...
BioCentury | Oct 28, 2013
Finance

Hoping to give thanks

...Ltd. (NSE; BSE) 6/26/13 Up to Rs3B ($50.6M) Mkt (drug) BofA Merrill Lynch; Morgan Stanley; IDFC Capital...
BioCentury | Jul 15, 2013
Financial News

Emcure proposes IPO

...to Rs3 billion ($50.6 million) Shares: TBD Price: TBD Underwriters: BofA Merrill Lynch; Morgan Stanley; IDFC Capital...
BioCentury | Jul 3, 2013
Financial News

Emcure, Intas file for Indian IPOs

...plan to sell 2.5 million Emcure shares in conjunction with the offering. BofA Merrill Lynch; IDFC Capital...
Items per page:
1 - 5 of 5